Related Experiment Video

Updated: Jul 16, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice

A de La Coste1, A Mignon, M Fabre

  • 1Institut National de la Santé et de la Recherche, U129, ICGM, Université Paris V René Descartes, France.

Cancer Research
|October 16, 1999
PubMed

Insights

The anti-cancer gene Bcl-2 inhibits liver tumor formation by suppressing early cell growth and apoptosis in a mouse model. This tumor suppressor effect was specific to Bcl-2, highlighting its unique role in preventing neoplastic foci.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Tumorigenesis involves complex genetic and cellular changes, including altered apoptosis and proliferation.
  • Understanding the role of specific genes, such as antiapoptotic genes, in cancer progression is crucial for developing targeted therapies.
  • Hepatocarcinogenesis, liver cancer development, can be studied using genetically modified mouse models to investigate oncogenic pathways.

Purpose of the Study:

  • To investigate the role of antiapoptotic genes in the multistage process of c-myc-induced hepatocarcinogenesis.
  • To determine if coexpressing antiapoptotic genes, specifically Bcl-2, can inhibit liver tumor formation.
  • To elucidate the specific mechanisms by which Bcl-2 influences tumor suppressor effects in vivo.

Main Methods:

  • Utilized transgenic mice with c-myc gene overexpression in the liver to induce hepatocarcinogenesis.
  • Analyzed the effect of coexpressing various antiapoptotic genes (Bcl-2, Bcl-xL, dominant-negative p53) on tumor development.
  • Monitored and quantified changes in proliferation and apoptosis during pre-tumoral phases and tumor emergence.

Main Results:

  • Continuous c-myc overexpression led to hepatocellular carcinoma.
  • Coexpression of the Bcl-2 gene significantly inhibited liver tumor emergence by suppressing a pre-tumoral phase characterized by increased proliferation and apoptosis.
  • The tumor suppressor effect was specific to Bcl-2; Bcl-xL and dominant-negative p53 did not show similar inhibitory effects.

Conclusions:

  • Bcl-2 demonstrates a significant tumor suppressor effect in vivo during the early stages of c-myc-induced hepatocarcinogenesis.
  • Bcl-2's ability to inhibit proliferation and apoptosis in pre-neoplastic lesions is key to its anti-oncogenic function.
  • This study highlights the specific and crucial role of Bcl-2 in preventing the development of liver tumors.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...